Potential in vivo generator for alpha-particle therapy with 212Bi: Presentation of a system to minimize escape of daughter nuclide after decay of 212Pb to 212Bi

Radiochimica Acta

Volumn 91, Issue 2, 2003, Pages 109-113

  Henriksen, Gjermund ^a,b   Schoultzt, Bent W ^a,b   Hoff, Per ^a   Larsen, Roy H ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b Anticancer Therapeutic Inventions AS   (Norway)

Author keywords

212Bi in vivo generator; 212Pb; Alpha particle emitters; Liposomes; Targeted radiotherapy

Indexed keywords

BISMUTH; BISMUTH 212; DRUG CARRIER; LEAD 212; LIPOSOME; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ALPHA RADIATION; ARTICLE; DRUG FORMULATION; GENERATOR; HUMAN; RADIOCHEMISTRY; SERUM; TECHNOLOGY;

EID: 0042315208     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.91.2.109.19988     Document Type: Article

References (35)

1. Feinendegen, L. E., McClure J. J.: α-emitters for medical therapy. Radiat Res. 148, 195 (1997).
2. Fisher, D. R., Harty, R.: The microdosimetry of lymphocytes irradiated by alpha particles. Int. J. Radiat. Biol. 41, 315 (1982).
3. Humm, J. L., Roeske, J. C., Fisher, D. R., Chen, G. T. Y.: Microdosimetric concepts in radioimmunotherapy. Med. Phys. 20, 535 (1993).
4. McDevitt, M. R., Sgouros, G., Finn, R. D., Humm, J. L., Jurcic, J. G., Larson, S. M., Scheinberg, D. A.: Radioimmunotherapy with alpha-emitting nuclides. Eur. J. Nucl. Med. 25, 1341 (1998).
5. Kozak, R. W., Atcher, R. W., Gansow, O. A., Friedman, A. M., Hines, J. J., Waldman, T. A.: Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy. Proc. Natl. Acad. Sci. USA 83, 474 (1986).
6. 212Bi-anti-Tac. Cancer Res. 54, 4362 (1994).
7. 212Bi. Appl. Radiat. Isot. 39, 282 (1988).
8. 225Ac. Radiochim. Acta. 79, 141 (1997).
9. 213Bi generator system for therapeutic clinical applications: construction and operation. Appl. Radiat. Isot. 50, 895 (1999).
10. Zindenberg-Cherr, S., Parks, N. J., Keen, C.L: Tissue and subcellular distribution of bismuth radiotracer in the rat: Considerations of cytotoxicity and microdosimetry for bismuth radiopharmaceuticals. Radiat. Res. 111, 119 (1987).
11. 212Pb-DOTA. Radiochim. Acta 60, 1 (1993).
12. 212Pb-labeled monoclonal antibody in the treatment of murine erythroleukemia. Int. J. Radiat. Oncol. Biol. Phys. 34, 609 (1996).
13. Hassfjell, S. P., Bruland, Ø. S., Hoff, P.: Bi-212-DOTMP: An alpha particle emitting bone-seeking agent for targeted radiotherapy. Nucl. Med. Biol. 24, 231 (1997).
14. Kostarelos, K., Emfietzoglou, D.: Liposomes as carriers of radionuclides: From imaging to therapy. J. Liposome. Res. 9, 429 (1999).
15. Kostarelos, K., Emfietzoglou, D.: Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: Toward liposome-targeted therapeutic radiopharmaceutical. Anticancer Res. 20, 3339 (2000).
16. Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, R. C., Baldeschwieler, J. D.: 1983. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J. Nucl. Med. 24, 45 (1983).
17. 67Ga-carrying liposomes. Eur. J. Nucl. Med. 11, 405 (1986).
18. Presant, C. A., Proffitt, R. T., Turner, A. F., Winsor, D., Werner, J. L., Williams, L. E., Kennedy, P., Wiseman, C., Gala, K., McKenna, R. J., Smith, J. D., Sakulsky, S. B., Bouzaglou, A., Callahan, R. A., Baldeschwieler, J. D., Crossley R. J.: Successful imaging of human cancer with radiolabeled phospholipid vesicles (liposomes). Cancer 62, 905 (1988).
19. Presant, C. A., Turner, A. F., Proffitt, R. T.: Potential for improvement in clinical decision-making: tumor imaging with In-111 labeled liposomes results of a Phase II-III study. J. Liposome Res. 4, 985 (1994).
20. Senior, J., Delgado, C., Fisher, D., Tilcock, C., Gregoriadis, G.: Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062, 77 (1991).
21. Allen, T. M., Hansen, C. B., Lopes de Menezes, D. E.: Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 16, 267 (1995)
22. Zalipsky, S., Hansen, C. B., Lopes de Menezes, D. E., Allen, T. M.: Long-circulating, polyethylene glycol-grafted immunoliposomes. J. Contr. Release 39, 153 (1995).
23. MacDonald, R. C., MacDonald, R. I., Menco, B. P. M., Takeshita, K., Subbarao, N. K., Lan-rong, H.: Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochem. Biophys. Acta 1061, 297 (1991).
24. Brown, J. C., Pusey, P. N.: Photon correlation study of polydisperse samples of polystyrene in cyclohexane. J. Chem. Phys. 62, 1136 (1975).
25. López-Amanya, C., Marangoni, A. G.: Comparison of dynamic and integrated light-scattering techniques in the study of the interaction of Candida rugosa lipase with DPPC liposomes. Biophys. Chem. 80, 69 (1999).
26. 212Bi. Appl. Radiat. Isot. 45, 1021 (1994).
27. Mauk, M. R., Gamble, R. C.: Preparation of lipid vesicles containing high levels of entrapped radioactive cations. Anal. Biochem. 94, 302 (1979).
28. Tilcock, C. P., Ahkong, Q. F., Parr, M.: An improved method for the preparation of liposomal gadolinium-DTPA. Ionophore-mediated active entrapment of gadolinium. Invest. Radiol. 26, 242 (1991).
29. Bartlett G. R.: Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466 (1958).
30. Kirpotin, D., Park, J. W., Hong, K., Zalipsky, S., Wen-Lu, L., Carter, P., Benz, C. C., Papahadjopoulos, D.: Sterically stabilised Anti-HER2 Immunoliposomes: Design and targeting to human breast cancer cells in vitro. Biochemistry 36, 66 (1997).
31. Cheng, K. T., Seltzer, S. E., Adams, D. F., Blau, M.: The production and evaluation of contrast carrying liposomes made with an automated high pressure system. Invest. Radiol. 22, 47 (1987).
32. Tilcock, C., Unger, E., Cullis, P., MacDougall, P.: Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 171, 77 (1989).
33. Park, J. W.: Liposome based drug delivery in breast cancer treatment. Breast Cancer Res. 4, 95 (2002).
34. Park J. W. Kirpotin, D. B., Hong, K., Shalaby, R., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., Benz, C. C.: Tumor targeting using anti-her2 immunoliposomes. J. Control Release 74, 95 (2001).
35. Shimura, N., Sogawa, Y., Kawakita, Y., Ikekita, M., Yamazaki, N., Kojima, S.: Radioiodination of glycoprotein-conjugated liposomes by using the Bolton-Hunter reagent and biodistribution in tumor-bearing mice. Nucl. Med. Biol. 29, 491 (2002).